MétaCan
Menu
Back to cohort
Record W4409350486 · doi:10.1200/cci.24.00114

Machine Learning Models of Early Longitudinal Toxicity Trajectories Predict Cetuximab Concentration and Metastatic Colorectal Cancer Survival in the Canadian Cancer Trials Group/AGITG CO.17/20 Trials

2025· article· en· W4409350486 on OpenAlex
Danielle Lilly Nicholls, Maria C. Xu, Luna Jia Zhan, Divya Sharma, Katrina Hueniken, Kaitlyn Chiasson, M. Catherine Brown, Benjamin Grant, Jeremy Shapiro, Christos S. Karapetis, R. J. Simes, Derek J. Jonker, Dongsheng Tu, Christopher O’Callaghan, Eric X. Chen, Geoffrey Liu

Why this work is in the frame

A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.

affAt least one author lists a Canadian institution in the pinned OpenAlex snapshot.
aboutThe title or abstract carries a Canadian signal from the geographic lexicon.

Bibliographic record

VenueJCO Clinical Cancer Informatics · 2025
Typearticle
Languageen
FieldMedicine
TopicColorectal Cancer Treatments and Studies
Canadian institutionsQueen's UniversityPrincess Margaret Cancer CentreOttawa HospitalUniversity of OttawaPublic Health OntarioUniversity of Toronto
Fundersnot available
KeywordsCetuximabMedicineToxicityColorectal cancerInternal medicineOncologyRashHazard ratioProportional hazards modelPlaceboCancerPathologyConfidence interval

Abstract

fetched live from OpenAlex

PURPOSE Cetuximab (CET), targeting the epidermal growth factor receptor, is a systemic treatment option for patients with colorectal cancer. One known predictive factor for CET efficacy is the presence of CET-related rash; other putative toxicity factors include fatigue and nausea. Analysis of early CET-associated toxicities may reveal patient subpopulations that clinically benefit from long-term CET treatment. METHODS We analyzed data from CO.20 (ClinicalTrials.gov identifier: NCT00640471 ) trial arms, CET + brivanib alaninate (BRIV) (n = 376) and CET + placebo (n = 374), and CO.17 (ClinicalTrials.gov identifier: NCT00079066 ) trial arms, CET (+best supportive care [BSC]; n = 287) and BSC only (n = 285). Patients were clustered into subpopulations using KmL3D, a machine learning method, to analyze 14 joint longitudinal toxicity trajectories from weeks 0 to 8 of treatment. Landmark survival analyses were performed from 8 weeks after treatment initiation. Regression analyses assessed the relationship between subpopulations and plasma CET concentrations. Three supervised machine learning models were developed to assign patients in the CO.20-CET trial arm into subpopulations, which were then validated using CO.20-CET-BRIV and CO.17-CET trial arm data. RESULTS Joint longitudinal toxicity clustering revealed dichotomous high- and low-toxicity clusters, with all CET-containing arms showing consistent toxicity trajectories and characteristics. High-toxicity clusters were associated with male predilection, fewer metastatic sites, fewer colon-only primaries, and higher body mass indices. In CO.20 trial samples, higher toxicity clusters were associated with improved overall survival and progression-free survival outcomes (adjusted hazard ratios ranging from 2.21 to 4.36) and higher CET concentrations ( P = .003). The random forest predictive model performed the best, with an AUC of 0.981 (0.963-0.999). CONCLUSION We used an innovative machine learning approach to analyze longitudinal joint drug toxicities, demonstrating their role in predicting patient outcomes through a putative pharmacokinetic mechanism.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.006
metaresearch head score (Gemma)0.002
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.493
Threshold uncertainty score0.943

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0060.002
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0020.000
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.220
GPT teacher head0.445
Teacher spread0.225 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it